Skip Header

You are using a version of browser that may not display all the features of this website. Please consider upgrading your browser.
1 to 25 of 72  Show

Literature citations Results

Genomic alterations in BCL2L1 and DLC1 contribute to drug sensitivity in gastric cancer.

Park H., Cho S.Y., Kim H., Na D., Han J.Y., Chae J., Park C., Park O.K., Min S., Kang J. et al.

Proc. Natl. Acad. Sci. U.S.A. 112:12492-12497(2015) · Mapped (8)

Integrative genomics of gene and metabolic regulation by estrogen receptors alpha and beta, and their coregulators.

Madak-Erdogan Z., Charn T.H., Jiang Y., Liu E.T., Katzenellenbogen J.A., Katzenellenbogen B.S.

Mol. Syst. Biol. 9:676-676(2013) · Mapped (84)

Regulation of transcription through acetylation of H3K122 on the lateral surface of the histone octamer.

Tropberger P., Pott S., Keller C., Kamieniarz-Gdula K., Caron M., Richter F., Li G., Mittler G., Liu E.T., Buhler M. et al.

Cell 152:859-872(2013) · UniProtKB (5)

PPARG binding landscapes in macrophages suggest a genome-wide contribution of PU.1 to divergent PPARG binding in human and mouse.

Pott S., Kamrani N.K., Bourque G., Pettersson S., Liu E.T.

PLoS ONE 7:e48102-e48102(2012) · Mapped (13)

Heterogeneous epigenetic regulation of TIMP3 in prostate cancer.

Shinojima T., Yu Q., Huang S.K., Li M., Mizuno R., Liu E.T., Hoon D.S., Lessard L.

Epigenetics 7:1279-1289(2012) · Mapped (3)

JMJD6 is a driver of cellular proliferation and motility and a marker of poor prognosis in breast cancer.

Lee Y.F., Miller L.D., Chan X.B., Black M.A., Pang B., Ong C.W., Salto-Tellez M., Liu E.T., Desai K.V.

Breast Cancer Res. 14:R85-R85(2012) · Mapped (4)

Cellular reprogramming by the conjoint action of ERalpha, FOXA1, and GATA3 to a ligand-inducible growth state.

Kong S.L., Li G., Loh S.L., Sung W.K., Liu E.T.

Mol. Syst. Biol. 7:526-526(2011) · Mapped (76)

Combined genomic and phenotype screening reveals secretory factor SPINK1 as an invasion and survival factor associated with patient prognosis in breast cancer.

Soon W.W., Miller L.D., Black M.A., Dalmasso C., Chan X.B., Pang B., Ong C.W., Salto-Tellez M., Desai K.V., Liu E.T.

EMBO Mol Med 3:451-464(2011) · Mapped (3)

Molecular conservation of estrogen-response associated with cell cycle regulation, hormonal carcinogenesis and cancer in zebrafish and human cancer cell lines.

Lam S.H., Lee S.G., Lin C.Y., Thomsen J.S., Fu P.Y., Murthy K.R., Li H., Govindarajan K.R., Nick L.C., Bourque G. et al.

BMC Med Genomics 4:41-41(2011) · Mapped (44)

Transcriptional consequences of genomic structural aberrations in breast cancer.

Inaki K., Hillmer A.M., Ukil L., Yao F., Woo X.Y., Vardy L.A., Zawack K.F., Lee C.W., Ariyaratne P.N., Chan Y.S. et al.

Genome Res. 21:676-687(2011) · Mapped (8)

Genetic variation of ESR1 and its co-activator PPARGC1B is synergistic in augmenting the risk of estrogen receptor-positive breast cancer.

Li Y., Li Y., Wedren S., Li G., Charn T.H., Desai K.V., Bonnard C., Czene K., Humphreys K., Darabi H. et al.

Breast Cancer Res. 13:R10-R10(2011) · Mapped (3)

Trefoil factor 3 is oncogenic and mediates anti-estrogen resistance in human mammary carcinoma.

Kannan N., Kang J., Kong X., Tang J., Perry J.K., Mohankumar K.M., Miller L.D., Liu E.T., Mertani H.C., Zhu T. et al.

Neoplasia 12:1041-1053(2010) · Mapped (2)

A genome-wide association study of nasopharyngeal carcinoma identifies three new susceptibility loci.

Bei J.X., Li Y., Jia W.H., Feng B.J., Zhou G., Chen L.Z., Feng Q.S., Low H.Q., Zhang H., He F. et al.

Nat. Genet. 42:599-603(2010) · Mapped (32)

Early B cell factor 1 regulates B cell gene networks by activation, repression, and transcription- independent poising of chromatin.

Treiber T., Mandel E.M., Pott S., Gyory I., Firner S., Liu E.T., Grosschedl R.

Immunity 32:714-725(2010) · Mapped (9)

Genome-wide dynamics of chromatin binding of estrogen receptors alpha and beta: mutual restriction and competitive site selection.

Charn T.H., Liu E.T., Chang E.C., Lee Y.K., Katzenellenbogen J.A., Katzenellenbogen B.S.

Mol. Endocrinol. 24:47-59(2010) · Mapped (72)

An oestrogen-receptor-alpha-bound human chromatin interactome.

Fullwood M.J., Liu M.H., Pan Y.F., Liu J., Xu H., Mohamed Y.B., Orlov Y.L., Velkov S., Ho A., Mei P.H. et al.

Nature 462:58-64(2009) · Mapped (72)

RCP is a human breast cancer-promoting gene with Ras-activating function.

Zhang J., Liu X., Datta A., Govindarajan K., Tam W.L., Han J., George J., Wong C., Ramnarayanan K., Phua T.Y. et al.

J. Clin. Invest. 119:2171-2183(2009) · Mapped (7)

Common genetic variability in ESR1 and EGF in relation to endometrial cancer risk and survival.

Einarsdottir K., Darabi H., Czene K., Li Y., Low Y.L., Li Y.Q., Bonnard C., Wedren S., Liu E.T., Hall P. et al.

Br. J. Cancer 100:1358-1364(2009) · Mapped (75)

De-novo identification of PPARgamma/RXR binding sites and direct targets during adipogenesis.

Hamza M.S., Pott S., Vega V.B., Thomsen J.S., Kandhadayar G.S., Ng P.W., Chiu K.P., Pettersson S., Wei C.L., Ruan Y. et al.

PLoS ONE 4:e4907-e4907(2009) · Mapped (14)

Functional analysis of a cell cycle-associated, tumor-suppressive gene, protein tyrosine phosphatase receptor type G, in nasopharyngeal carcinoma.

Cheung A.K., Lung H.L., Hung S.C., Law E.W., Cheng Y., Yau W.L., Bangarusamy D.K., Miller L.D., Liu E.T., Shao J.Y. et al.

Cancer Res. 68:8137-8145(2008) · Mapped (7)

Regulation of estrogen receptor-mediated long range transcription via evolutionarily conserved distal response elements.

Pan Y.F., Wansa K.D., Liu M.H., Zhao B., Hong S.Z., Tan P.Y., Lim K.S., Bourque G., Liu E.T., Cheung E.

J. Biol. Chem. 283:32977-32988(2008) · Mapped (72)

Zebrafish whole-adult-organism chemogenomics for large-scale predictive and discovery chemical biology.

Lam S.H., Mathavan S., Tong Y., Li H., Karuturi R.K., Wu Y., Vega V.B., Liu E.T., Gong Z.

PLoS Genet. 4:e1000121-e1000121(2008) · Mapped (141)

Patients with acute myeloid leukemia and RAS mutations benefit most from postremission high-dose cytarabine: a Cancer and Leukemia Group B study.

Neubauer A., Maharry K., Mrozek K., Thiede C., Marcucci G., Paschka P., Mayer R.J., Larson R.A., Liu E.T., Bloomfield C.D.

J. Clin. Oncol. 26:4603-4609(2008) · Mapped (5)

DACT3 is an epigenetic regulator of Wnt/beta-catenin signaling in colorectal cancer and is a therapeutic target of histone modifications.

Jiang X., Tan J., Li J., Kivimae S., Yang X., Zhuang L., Lee P.L., Chan M.T., Stanton L.W., Liu E.T. et al.

Cancer Cell 13:529-541(2008) · UniProtKB (1) · Mapped (11)

Estrogen receptor regulation of carbonic anhydrase XII through a distal enhancer in breast cancer.

Barnett D.H., Sheng S., Charn T.H., Waheed A., Sly W.S., Lin C.Y., Liu E.T., Katzenellenbogen B.S.

Cancer Res. 68:3505-3515(2008) · Mapped (75)

1 to 25 of 72  Show